The Listed Edge | Jhajj Gurbag Singh | Substack

Novo Nordisk A/S (NVO): Can the Weight Loss King Recover from Its Worst Year Ever?

As shares hover near multi-year lows at $57.47, a mounting question about the ability to defend its obesity empire.

Jan 7 • Jhajj Gurbag Singh

Power Solutions International (NASDAQ: PSIX): Growth Ignites, Conviction Tested

Data-Center Tailwinds Push Technical Upside While Credibility Risks Shape the Trade

Dec 21, 2025 • Jhajj Gurbag Singh

Pagaya Technologies Ltd. (NASDAQ: PGY)

AI-Driven Credit Infrastructure Under Stress: Growth, Volatility, and Sustainability

Dec 13, 2025 • Jhajj Gurbag Singh

5:18

Stantec Inc.: Engineering Success or Overvalued Illusion?

Why a 38x P/E Multiple and Slowing US Growth Could Signal Trouble Ahead for This Canadian Infrastructure Giant

Dec 5, 2025 • Jhajj Gurbag Singh

2:28

Agnico Eagle Mines: Riding a Golden Wave — But Storm Clouds Build Beneath

Is the CAD 243 rally sustainable, or are investors ignoring risks hiding in plain sight?

Nov 28, 2025 • Jhajj Gurbag Singh

The Listed Edge

About Archive Sitemap

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts